Observational study to evaluate bipolar disorder symptoms in patients presented with schizophrenia or depression
Study identifier:NIS-NRU-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Epidemiological observational non-interventional study to research the prevalence of bipolar criteria of hospital In-patients with schizophrenia and patients with recurrent depression
Medical condition
schizophrenia
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
750
Study type
Observational
Age
18 Years - 65 Years
Date
Study Start Date: 01 Nov 2009
Primary Completion Date: 01 Nov 2010
Study Completion Date: 01 Nov 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 - schizophrenia Psychiatrists will enrol patients meeting inclusion/exclusion criteria with schizophrenia as they routinely attend the clinic or are examined in hospital in a consecutively manner. | - |
| 2 - recurrent depression Psychiatrists will enrol patients meeting inclusion/exclusion criteria with recurrent depression as they routinely attend the clinic or are examined in hospital in a consecutively manner. | - |
Contacts
Investigators
Principal Investigator
Sergey N. Mosolov
Mental Disorders Moscow Research Institute of Psychiatry
